Gonococcal proctitis is usually acquired sexually and is most commonly seen in individuals who practice receptive anal intercourse. Proctitis alone may not produce systemic symptoms such as fever. Moreover, a large proportion of those affected are asymptomatic [1]. Symptomatic infection may present as gastrointestinal complaints that include tenesmus, diarrhea, lower abdominal pain in the left quadrant, and stool withholding behavior due to pain during defecation. A mucopurulent rectal discharge, rectal bleeding, and less commonly anal pain and itching may also be described. These clinical manifestations often appear a few days after anal intercourse without the use of a barrier protective method, and the disease course may either be acute or chronic. Furthermore, the presence of pharyngeal and genital gonococcal invasion may indicate the possibility of rectal infection [2]. This is particularly useful as some signs which are seen with gonococcal proctitis may be identical to those found in other inflammatory bowel conditions.

Visualization of the rectal mucosa through proctoscopy may reveal normal or inflamed mucosa, and in some cases, abscesses. Lesions do not normally extend past the dentate line to the anus, but those that do are more likely to produce symptoms.

A sexual history should be noted, and physical examination of the anus, genital tract and abdomen are important. The rectal mucosa can be inspected via proctoscopy, to note any pustules, erythema, ulcers or bleeding. The absence of lesions and an apparently normal mucosa do not rule out gonococcal proctitis. In addition, colonoscopy should be simultaneously performed, in order to view the extent of inflammation, as it may involve the sigmoid colon.

Rectal swabs must be taken from the rectal mucosa and from any discharge which is present. These samples can be tested in a number of ways:

• Gram staining and microscopy: Failure to detect gonococcal organisms does not rule out infection, and because this test is operator dependent, sensitivity is compromised [3] [4]. Despite this, its possible sensitivity is as high as 95% [2]. The concurrent use of other tests is recommended.
• Culture: This is currently the gold standard test.
• Polymerase chain reaction (PCR): PCR has a high sensitivity, hence its frequent use.
• Nucleic acid hybridization test
• Nucleic acid amplification test (NAAT): There is no consensus among medical professionals on the use of NAAT, and it is generally unauthorized for use on the rectal mucosa, however, many practitioners and laboratories have used it with success, under specific procedural guidelines [5] [6].

Genital and pharyngeal swabs may also be cultured along with rectal swabs. Further laboratory tests to be carried out are complete blood count, where a raised leukocyte count may be present, as well as anemia due to rectal hemorrhage, and the measurement of inflammatory markers such as C-reactive protein (CRP) which may be elevated, especially in patients with proximal involvement of the colon. Testing for chlamydial infection is indicated as co-infection is common. Partners of infected persons should also be notified and treated. Other organisms that may be tested include herpes simplex virus and Treponema pallidum, using the appropriate diagnostic tools.

The treatment of gonococcal proctitis involves antibiotics to eradicate the infection. The Centers for Disease Control and Prevention (CDC) recommends a dual therapy approach, typically involving an injection of ceftriaxone and oral azithromycin. It is important for patients to complete the full course of antibiotics even if symptoms improve. Sexual partners should also be notified, tested, and treated to prevent reinfection and further transmission.

With appropriate antibiotic treatment, the prognosis for gonococcal proctitis is generally excellent. Most patients experience a complete resolution of symptoms within a few days to a week. However, untreated gonococcal proctitis can lead to complications, such as the spread of the infection to other parts of the body or increased susceptibility to other STIs, including HIV.

Gonococcal proctitis is caused by the bacterium Neisseria gonorrhoeae. This bacterium is transmitted through sexual contact, including anal intercourse. The infection occurs when the bacteria invade the mucous membranes of the rectum, leading to inflammation and the characteristic symptoms of proctitis.

Gonococcal proctitis is more common in populations with higher rates of gonorrhea, particularly among men who have sex with men (MSM). The prevalence of gonorrhea and related conditions like proctitis can vary by region and is influenced by factors such as sexual behavior, access to healthcare, and public health initiatives.

The pathophysiology of gonococcal proctitis involves the invasion of rectal mucosa by Neisseria gonorrhoeae. The bacteria attach to the epithelial cells lining the rectum, triggering an inflammatory response. This inflammation results in the symptoms of pain, discharge, and irritation. The body's immune response aims to clear the infection, but without treatment, the bacteria can persist and cause ongoing symptoms.

Preventing gonococcal proctitis involves reducing the risk of exposure to Neisseria gonorrhoeae. Safe sexual practices, such as using condoms during anal intercourse, can significantly lower the risk of transmission. Regular STI screenings for sexually active individuals, especially those with multiple partners, are also important for early detection and treatment of infections.

Gonococcal proctitis is an inflammation of the rectum caused by the bacterium Neisseria gonorrhoeae. It is a sexually transmitted infection that can cause symptoms like rectal pain, discharge, and itching. Diagnosis involves clinical evaluation and laboratory testing, while treatment requires antibiotics. With proper management, the prognosis is excellent, but prevention through safe sexual practices is key to reducing the risk of infection.

If you suspect you have gonococcal proctitis, it is important to seek medical evaluation. Symptoms can include rectal pain, discharge, and itching. Diagnosis is confirmed through specific tests, and treatment involves antibiotics. Practicing safe sex and getting regular STI screenings can help prevent this condition. If diagnosed, ensure that your sexual partners are informed and treated to prevent reinfection.

1. Kent CK, Chaw JK, Wong W, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis. 2005;41(1):67–74.
2. Bignell C, Fitzgerald M. UK national guideline for the management of gonorrhoea in adults. Int J STD AIDS. 2011;22(10):541–547.
3. Sherrard J, Barlow D. Gonorrhoea in men: clinical and diagnostic aspects. Genitourin Med. 1996;72(6):422–426.
4. Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010;59(RR-12):1–110.
5. Deheragoda P. Diagnosis of rectal gonorrhoea by blind anorectal swabs compared with direct vision swabs taken via a proctoscope. Br J Vener Dis. 1977;53(5):311–313.
6. Centers for Disease Control and Prevention (CDC). Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. 2007;56(14):332–336.